Katherine G. Evans

MARC Format Integration and Seriality

Katherine G. Evans, 1990 .

Vorinostat for the treatment of bullous pemphigoid in the setting of advanced, refractory cutaneous T-cell lymphoma.

Katherine G. Evans, Ellen J. Kim, A. Rook, 2009, Archives of dermatology.

Update on treatment of cutaneous T-cell lymphoma

Katherine G. Evans, Ellen J. Kim, A. Rook, 2009, Current opinion in oncology.

High clinical response rate of Sezary syndrome to immunomodulatory therapies: prognostic markers of response.

Katherine G. Evans, J. Gelfand, Ellen J. Kim, 2011, Archives of dermatology.

Improvement in peripheral blood disease burden in patients with Sézary syndrome and leukemic mycosis fungoides after total skin electron beam therapy.

Katherine G. Evans, Ellen J. Kim, A. Rook, 2013, Journal of the American Academy of Dermatology.

Immune modulators as therapeutic agents for cutaneous T-cell lymphoma.

Katherine G. Evans, M. Wasik, L. Showe, 2010, Clinical lymphoma, myeloma & leukemia.

Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppression.

Katherine G. Evans, E. Wherry, L. Showe, 2010, Archives of dermatology.